ReviewCognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions
Introduction
Clinical observations, conventional wisdom, and well-reasoned theoretical mechanisms, suggest that the acute and chronic use of psychoactive substances would impair cognitive functioning of individuals. Could this impairment be a specific effect with regard to specific drugs of abuse or is it a general impact on the brain? This review compares findings from other drugs of abuse according to how cannabis impairs human cognition, with regard to attention, memory and executive functions. The executive functions are a group of superior abilities of organization and integration that have been neuroanatomically associated with different neural interaction pathways involving the prefrontal cortex (Roberts et al., 1998). These include anticipating and establishing goals, designing plans and programs, self-regulation and monitoring of tasks, and effective execution and feedback (Lezak, 1995).
To reduce the scope of this review the focus will be on the abuse of amphetamine and methamphetamine, MDMA or similar synthetic amphetamine derivates, cocaine, and heroin.
Recent studies of the acute and chronic effects of specific drugs of abuse on human cognition have shown a cluster of cognitive, behavioural or physiological symptoms. Hall et al. (1999) compared the health effects of cannabis to other drugs by using the same standards that have been used to appraise the health effects of other drugs. The analysis, which was undertaken at the request of the WHO Committee on the health, proved difficult. The analysis was hindered by a dearth of epidemiological studies of consequences of cannabis use that would permit quantitative comparisons.
Other attempts to investigate this area have been made by Rogers and Robbins (2001) and Vik et al. (2004), and Verdejo-Garcia et al. (2005). Rogers and Robbins (2001) reviewed the neurocognitive deficits associated with chronic drug misuse and concluded that chronic and heavy use of cannabis may be associated with quite subtle changes in cognitive, particularly attentional function, but whether such changes are permanent remains unclear, that chronic amphetamine abuse is associated with altered functioning of the circuitry, involving the ventral prefrontal cortex (PFC) that mediates decision-making. This is consistent with earlier results indicating that prolonged stimulant use (cocaine) is associated with altered metabolism in the orbital cortex (Volkow et al., 1993). It is also consistent with the finding of high densities of the cannabinoid receptor in the cerebral cortex and hippocampus (Herkenham et al., 1990), hypothesising that cannabinoids are involved in attentional and memory processes. Vik et al. (2004) conclude that acute intoxication and immediate and protracted withdrawal produce transient alterations of cognitions that can persist for weeks to months. Some subtle residual effects remain for up to 1 year for certain drugs. Evidence of irreversible effects is less clear. In comparison with cannabis and stimulants, there has been substantially less research into neuropsychological deficits in chronic abusers of opiates. Verdejo-Garcia et al. (2005) analyzed the relationship between severity of consumption of different drugs and neuropsychological performance on tasks sensitive to impairment in the executive subprocesses of working memory, response inhibition, cognitive flexibility, and abstract reasoning. The results showed a differential impact of severity of MDMA abuse on working memory and abstract reasoning indices, of cocaine severity on an inhibitory control index and of cannabis on a cognitive flexibility index.
Most of the neurotransmitters affected by drugs of abuse exert their effects through relatively diffuse patterns of innervations across the whole of the forebrain and wider cortical areas. It is therefore unsurprising that there have been relatively few, if any, convincing demonstrations of differences in neurocognitive performance between abusers of different drugs of abuse.
Section snippets
Cannabis
Qualitative analyses of the cognitive consequences of cannabis use made by Hall et al. (1999) conclude, focusing on: acute effects that, cannabis induces loss of internal control and cognitive impairment, especially of attention and memory, for the duration of intoxication. Further, according to Hall et al. (1999), the major health and psychological effects of chronic heavy cannabis use, especially daily use over many years, remain uncertain. On the available evidence, the major probable
Amphetamine and methamphetamine
Neuroimaging studies have demonstrated that methamphetamine user exhibits various abnormalities in brain function relative to healthy controls. These include alterations in frontal, temporal, and subcortical brain metabolism (Gouzoulis-Mayfrank et al., 1999, Iyo et al., 1997, Volkow et al., 2001a), changes in brain metabolites suggestive of neuronal injury in the basal ganglia and frontal cortex (Ernst et al., 2000), and decreased density of dopaminergic neurons in the caudate and putamen (
Discussion
Searching PubMed (January 2005) for attention and memory gives the following top five in the abuse perspective; cannabis, cocaine, ecstasy, methamphetamine, heroin. The order probably well illustrates the prevalence of the drugs. When executive functioning was added to the search, only 10 studies for all the above mentioned drugs together were found. This indicates paucity in studies assessing drug abuser and executive functioning. The brain imaging studies contain the same technique but have
References (91)
- et al.
Chronic use and cognitive impairments
Pharmacol Biochem Behav
(2002) - et al.
Neuropsychological deficits and opiate abuse
Drug Alcohol Depend
(2002) - et al.
Abnormal brain activity in prefrontal brain regions in abstinent marijuana users
Neuroimage
(2004) - et al.
Effects of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: enhanced vasoconstriction at sites of significant stenosis
J Am Coll Cardiol
(1990) - et al.
Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG
Neuropsychopharmacology
(1999) - et al.
Neuropsychological deficit in polydrug users. A preliminary report of the findings of the collaborative neuropsychological study of polydrug users
Drug Alcohol Depend
(1977) - et al.
Effects of crack cocaine on neurocognitive function
Psychiatry Res
(1996) - et al.
Abnormal cerebral perfusion in chronic methamphetamine abusers: a study using 99MTc-HMPAO and SPECT
Prog Neuropsychopharmacol Biol Psychiatry
(1997) - et al.
Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia
Neuropsychopharmacology
(1997) - et al.
Frontal lobe dysfunction in long-term cannabis users
Neurotoxicol Teratol
(2001)
Depersonalization after marijuana smoking
Biol Psychiatry
Marijuana intoxication and brain activation in marijuana smokers
Life Sci
Effects of chronic cocaine abuse on memory and learning
Arch Clin Neuropsychol
Effects of smoking marijuana on brain perfusion and cognition
Neuropsychopharmacology
Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers
Neuropsychopharmacology
The impact of heroin on frontal executive functions
Arch Clin Neuropsychol
The residual neuropsychological effects of cannabis: the current status of research
Drug Alcohol Depend
Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons
Lancet
Investigating the neurocognitive deficits associated with chronic drug misuse
Curr Opin Neurobiol
Differential impairments of selective attention due to frequency and duration of cannabis use
Biol Psychiatry
Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis
Addict Behav
Cognitive impairment in substance abuse
Psychiatr Clin North Am
Cerebellar metabolic activation by delta-9-tetrahydrocannabinol in human brain: a study with positron emission tomography and 18F-2-fluoro-2-deoxyglucose
Psychiatr Res: Neuroimaging
Brain glucose metabolism in chronic marijuana users at baseline and during intoxication
Psychiatr Res: Neuroimaging
Brain reward circuitry: four circuit elements “wired” in apparent series
Brain Res Bull
High resolution brain SPECT imaging of marijuana smokers with AD/HD
J Psychoact Drugs
Neuropsychological deficits in chronic cocaine abusers
Int J Neurosci
Effects of chronic marijuana use on human cognition
Psychopharmacology
Effects of chronic marijuana use on regional cerebral blood flow during recall
Abstr-Soc Neurosci
Effects of frequent marijuana use on brain tissue volume and composition
Neuroreport
Cerebellar hypoactivity in frequent marijuana users
Neuroreport
Differential effects of cocaine alcohol on neurocognitive performance
Neurology
Dose-related neurocognitive effects of marijuana use
Neurology
Intellectual and neuropsychological functions in young men with heavy and long-term patterns of drug abuse
Am J Psychiatry
Contribution of cannabis and MDMA (“ecstasy”) to cognitive changes in long-term polydrug users
Psychopharmacology (Berl)
The hippocampus and behavior
Psychol Bull
From conditioning to conscious recollection
Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study
Neurology
Cognitive correlates of long term cannabis use in Costa Rican men
Arch Gen Psychiatry
Selective cognitive processing of drug cues in heroin dependence
J Psychopharmacol
Neurophysiological evidence for abnormal cognitive processing of drug cues in heroin dependence
Psychopharmacology (Berl)
Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the frontal cortex
Am J Psychiatry
Neurocognitive performances of methamphetamine users discordant for history of marijuana exposure
Drug Alcohol Depend
Comparing the health and psychological risks of alcohol, cannabis, nicotine and opiate use
Cannabinoidreceptor localization in brain
Proc Natl Acad Sci U S A
Cited by (256)
The neurocognitive correlates of non-substance addictive behaviors
2024, Addictive BehaviorsNo evidence of accelerated epigenetic aging among black heroin users: A case vs control analysis
2023, Addiction NeuroscienceTrauma exposure among cannabis use disorder individuals was associated with a craving-correlated non-habituating amygdala response to aversive cues.
2022, Drug and Alcohol Dependence ReportsMethamphetamine detection using nanoparticle-based biosensors: A comprehensive review
2022, Sensing and Bio-Sensing ResearchAttentional function and inhibitory control in different substance use disorders
2022, Psychiatry ResearchCitation Excerpt :For example, one study detected polysubstance use in biosamples of over 20% of fatally injured drivers (Brady and Li, 2013). Specific impairment of attention or reaction times (RT) during active intoxication by alcohol (Irwin et al., 2017), cannabis (Bondallaz et al., 2016; Ortiz-Peregrina et al., 2020), cocaine (Lundqvist, 2005), opioids (Cameron-Burr et al., 2021) or other narcotics (Saarialho-Kere et al., 1989) is well-documented. Less known are the chronic effects of these substances on attentional function (while not acutely intoxicated).